32
Participants
Start Date
January 1, 2024
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
Niacin
Intravenous administration of dose titrated from 10 µg·kg FFM-1·min-1 to 30 µg·kg for approximately 4.5 hours on one occasion
RECRUITING
Mayo Clinic, Rochester
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Mayo Clinic
OTHER